School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Department of Diagnostic Imaging, Royal Perth Hospital, Perth, Western Australia, Australia.
Atherosclerosis. 2020 Apr;298:52-57. doi: 10.1016/j.atherosclerosis.2020.03.001. Epub 2020 Mar 6.
Familial hypercholesterolaemia (FH) is characterised by a high, but variable risk of premature coronary artery disease (CAD). Cardiac computed tomography angiography (CCTA) can be employed to assess subclinical coronary atherosclerosis. We investigated the features and distribution of coronary artery plaques in asymptomatic patients with and without genetically confirmed heterozygous FH.
We undertook an aged-matched case-control study of asymptomatic phenotypic FH patients with (cases, M+) and without (controls, M-) an FH-causing mutation. Coronary atherosclerosis was assessed by CCTA and calcium scoring. Coronary segments were evaluated for global and vessel-level coronary plaques and degree of stenosis.
We studied 104 cases and 104 controls (mean age 49.9 ± 10.4 years), who had a similar spectrum of non-cardiovascular risk factors. Pre-treatment plasma LDL-cholesterol was higher in the M+ than M- group (7.8 ± 2.1 vs 6.2 ± 1.2 mmol/L, p<0.001). There was a greater proportion of patients with mixed and calcified plaque, as well as a higher coronary artery calcium score and segment stenosis score (all p<0.05), in the M+ compared with the M- group. M+ patients also had a significantly higher frequency of coronary artery calcium in the left main and anterior descending and right coronary arteries (all p<0.05), but not in the left circumflex.
Among patients with phenotypic FH, those with a genetically confirmed diagnosis had a higher frequency and severity of coronary atherosclerotic plaques, and specifically more advanced calcified plaques.
家族性高胆固醇血症(FH)的特征是具有较高但可变的早发冠心病(CAD)风险。心脏计算机断层扫描血管造影(CCTA)可用于评估亚临床冠状动脉粥样硬化。我们研究了有和没有遗传证实的杂合子 FH 患者无症状患者的冠状动脉斑块特征和分布。
我们进行了一项年龄匹配的病例对照研究,纳入了无症状表型 FH 患者(病例组,M+)和无 FH 致病突变的患者(对照组,M-)。通过 CCTA 和钙评分评估冠状动脉粥样硬化。评估冠状动脉节段的整体和血管水平的冠状动脉斑块和狭窄程度。
我们研究了 104 例病例和 104 例对照(平均年龄 49.9±10.4 岁),两组患者的非心血管危险因素谱相似。M+组治疗前血浆 LDL 胆固醇水平高于 M-组(7.8±2.1 比 6.2±1.2mmol/L,p<0.001)。M+组患者中混合性和钙化斑块的比例以及冠状动脉钙评分和节段狭窄评分均较高(均 p<0.05)。与 M-组相比,M+患者左主干、前降支和右冠状动脉的冠状动脉钙沉积也明显更频繁(均 p<0.05),但左回旋支没有。
在表型 FH 患者中,经基因确诊的患者具有更高的冠状动脉粥样硬化斑块频率和严重程度,特别是更严重的钙化斑块。